tradingkey.logo

SBC Medical Group Holdings Inc

SBC
4.540USD
+0.020+0.44%
Close 02/06, 16:00ETQuotes delayed by 15 min
465.70MMarket Cap
10.93P/E TTM

SBC Medical Group Holdings Inc

4.540
+0.020+0.44%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of SBC Medical Group Holdings Inc

Currency: USD Updated: 2026-02-06

Key Insights

SBC Medical Group Holdings Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered undervalued, ranking 109 out of 156 in the Professional & Commercial Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 8.17.In the medium term, the stock price is expected to trend up.

SBC Medical Group Holdings Inc's Score

Industry at a Glance

Industry Ranking
109 / 156
Overall Ranking
384 / 4521
Industry
Professional & Commercial Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

SBC Medical Group Holdings Inc Highlights

StrengthsRisks
SBC Medical Group Holdings Incorporated is a management company, which owns, operates, and provides management services to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including, but not limited to, advertising and marketing needs across various platforms, staff management, booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumable's procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic’s customer rewards program, and payment tools for the franchisee clinics.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 17.95% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 205.42M.
Fairly Valued
The company’s latest PE is 10.93, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 1.05M shares, decreasing 60.13% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 269.58K shares of this stock.

Analyst Rating

Based on 2 analysts
Buy
Current Rating
8.167
Target Price
+80.68%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of SBC Medical Group Holdings Inc is 6.34, ranking 124 out of 156 in the Professional & Commercial Services industry. Its financial status is robust, and its operating efficiency is low. Its latest quarterly revenue reached 43.35M, representing a year-over-year decrease of 18.33%, while its net profit experienced a year-over-year decrease of 352.70%.

Score

Industry at a Glance

Previous score
6.34
Change
0

Financials

9.95

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

4.58

Operational Efficiency

4.64

Growth Potential

5.51

Shareholder Returns

7.02

SBC Medical Group Holdings Inc's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of SBC Medical Group Holdings Inc is 8.39, ranking 33 out of 156 in the Professional & Commercial Services industry. Its current P/E ratio is 10.93, which is 272.63% below the recent high of 40.74 and 100.00% above the recent low of 0.00.

Score

Industry at a Glance

Previous score
8.39
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 109/156
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of SBC Medical Group Holdings Inc is 8.00, ranking 31 out of 156 in the Professional & Commercial Services industry. The average price target is 9.00, with a high of 9.00 and a low of 6.50.

Score

Industry at a Glance

Previous score
8.00
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 2 analysts
Buy
Current Rating
8.167
Target Price
+80.68%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

78
Total
5
Median
8
Average
Company name
Ratings
Analysts
SBC Medical Group Holdings Inc
SBC
2
PayPal Holdings Inc
PYPL
44
Block Inc
XYZ
44
Visa Inc
V
42
Fiserv Inc
FI
36
Fiserv Ord Shs
FISV
36
1
2
3
...
16

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

No price momentum score is currently available for SBC Medical Group Holdings Inc. The Professional & Commercial Services industry's average is 7.33.

Score

Industry at a Glance

Previous score
0.00
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(1)
Neutral(4)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
0.007
Buy
RSI(14)
54.961
Neutral
STOCH(KDJ)(9,3,3)
50.912
Neutral
ATR(14)
0.206
High Vlolatility
CCI(14)
43.892
Neutral
Williams %R
50.582
Neutral
TRIX(12,20)
0.207
Sell
StochRSI(14)
3.865
Oversold
Moving Average
Sell(1)
Neutral(0)
Buy(5)
Indicators
Value
Direction
MA5
4.616
Sell
MA10
4.456
Buy
MA20
4.438
Buy
MA50
4.235
Buy
MA100
4.033
Buy
MA200
4.170
Buy

Institutional Confidence

Currency: USD Updated: 2026-02-06

Score

Industry at a Glance

Previous score
3.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
Aikawa (Yoshiyuki)
92.69M
-0.29%
The Vanguard Group, Inc.
Star Investors
81.10K
+131.18%
BlackRock Institutional Trust Company, N.A.
251.51K
-0.25%
Geode Capital Management, L.L.C.
190.38K
+94.10%
Northern Trust Investments, Inc.
56.95K
+105.75%
Millennium Management LLC
50.46K
--
SBI Securities Co., Ltd.
52.47K
-3.15%
State Street Investment Management (US)
31.04K
+53.66%
BlackRock Investment Management, LLC
19.36K
+16.02%
AQR Capital Management, LLC
18.17K
--
1
2

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Professional & Commercial Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of SBC Medical Group Holdings Inc is 3.22, ranking 117 out of 156 in the Professional & Commercial Services industry. The company's beta value is 1.12. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.

Score

Industry at a Glance

Previous score
3.22
Change
0
Beta vs S&P 500 index
1.12
VaR
--
240-Day Maximum Drawdown
+46.28%
240-Day Volatility
+104.41%

Return

Best Daily Return
60 days
+9.33%
120 days
+20.24%
5 years
--
Worst Daily Return
60 days
-8.31%
120 days
-8.31%
5 years
--
Sharpe Ratio
60 days
+3.01
120 days
+0.68
5 years
--

Risk Assessment

Maximum Drawdown
240 days
+46.28%
3 years
+100.00%
5 years
--
Return-to-Drawdown Ratio
240 days
-0.07
3 years
-0.19
5 years
--
Skewness
240 days
-0.24
3 years
--
5 years
--

Volatility

Realised Volatility
240 days
+104.41%
5 years
--
Standardised True Range
240 days
+6.34%
5 years
--
Downside Risk-Adjusted Return
120 days
+117.07%
240 days
+117.07%
Maximum Daily Upside Volatility
60 days
+40.23%
Maximum Daily Downside Volatility
60 days
+32.64%

Liquidity

Average Turnover Rate
60 days
+0.10%
120 days
+0.08%
5 years
--
Turnover Deviation
20 days
-100.00%
60 days
-100.00%
120 days
-100.00%

Peer Comparison

Professional & Commercial Services
SBC Medical Group Holdings Inc
SBC Medical Group Holdings Inc
SBC
5.07 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Brady Corp
Brady Corp
BRC
8.77 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
McGrath RentCorp
McGrath RentCorp
MGRC
8.68 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Ennis Inc
Ennis Inc
EBF
8.64 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
RB Global Inc
RB Global Inc
RBA
8.48 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Brinks Co
Brinks Co
BCO
8.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI